Recent Articles

Farxiga: FDA Approves New Drug for Type 2 Diabetes

The FDA has approved a Type 2 Diabetes drug called Farxiga. However, the FDA is ordering post-approval studies to learn more about the drug's side effects. More 

5 Pharma Stocks to Buy for Big Dividends

Drugmakers aren't known for big dividends, but the pharmaceutical industry can actually offer something for income investors. More 

Diabetes Drug From BMY, AZN Gets Panel Recommendation

A FDA panel has voted to approve a diabetes drug rejected by the agency almost two years ago. More 

AstraZeneca Probed Over Heart-Drug Trial

British drug maker AstraZeneca says the U.S. Department of Justice is investigating a clinical trial of its Brilinta heart drug. More 

It May Be Time to Trim Away at Your Portfolio

The stock market is doing well for October, but its may be time to look through your portfolio in order to trim away some of the upcoming losers More 

Flu Season Is Coming — And These Companies Are Ready

Flu season is slowly getting started -- bad news for us, but welcome news for companies that benefit from flu sufferers' ills. Here's a look at some of them. More 

It’s Back to Business This Week for IPOs

FireEye and Rocket Fuel are among eight companies set to go public this week as the IPO market gets back into gear. More